Chronic pain affects more Americans than diabetes, cancer, and heart disease combined according to a recent article in Clincal & Forensic Toxicology News. The reasons are varied for testing for drugs in chronic pain patients as drugs are not just for pain relief, but may be used for misuse, addiction or diversion. That’s why the workshop presentation by Dr. Pierre Picard, VP R&D at Phytronix, Method Validation of 12 Benzodiazepines by LDTD-MS/MS Analysis in 6 seconds per sample with correlative data from LC-MS/MS for 200 real patient urine samples was of such interest at MSACL San Diego 2014.
If you weren’t able to attend the conference and workshop, but would still like to see it for yourself, Click Benzos in 6 seconds.
Overbrook Scientific represents the Phytronix LDTD ion source technology, used in national and regional toxicology and clinical settings nationwide. Numerous application notes, posters and scientific papers are available at LDTD App Notes and Posters.
To learn more, contact email@example.com, call 617-364-7683 or Contact Us.
MSACL is committed to the development of new technologies in mass spectrometry to be used in laboratory medicine; including diagnosis, treatment, and prognosis of clinical disorders. LDTD is one of those technologies.